OncoZenge AB (publ)

OM:ONCOZ Stock Report

Market Cap: SEK 60.3m

OncoZenge Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:ONCOZ Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Apr 25BuySEK 85,026Stian KildalIndividual20,439SEK 4.16
28 Mar 25BuySEK 118,200Stian KildalIndividual20,000SEK 5.91

Insider Trading Volume

Insider Buying: ONCOZ insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCOZ?
Owner TypeNumber of SharesOwnership Percentage
Private Companies260,0002.22%
VC/PE Firms1,170,6079.99%
Institutions1,980,64916.9%
General Public3,860,84933%
Individual Insiders4,441,13937.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 24 shareholders own 67.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.5%
Niclas Holmgren
1,463,590SEK 7.5m0%no data
9.99%
Linc AB
1,170,607SEK 6.0m0%0.34%
9.19%
Östersjöstiftelsen, Endowment Arm
1,076,408SEK 5.5m0%0.39%
4.93%
Avanza Fonder AB
578,048SEK 3.0m0%no data
4.27%
Andreas Ozbek
500,200SEK 2.6m0%no data
3.41%
Kalle Holmgren
400,000SEK 2.1m0%no data
2.78%
Nordnet AB (publ), Asset Management Arm
325,245SEK 1.7m0%0.02%
2.7%
Jimmy Olsson
316,000SEK 1.6m0%no data
2.69%
Stian Kildal
315,439SEK 1.6m6.93%no data
2.56%
Monica Holmgren Bergqvist
300,000SEK 1.5m0%no data
2.22%
Svenska Mäklarkontoret Ab
260,000SEK 1.3m0%no data
2.02%
Joacim Friberg Mansolahti
237,062SEK 1.2m0%no data
1.54%
Lisa Knight
180,000SEK 927.0k0%no data
1.05%
Fredrik Agren
123,231SEK 634.6k0%no data
1.02%
Gunvald Berger
120,000SEK 618.0k0%no data
1.01%
Pirkko Tamsen
118,007SEK 607.7k0%no data
0.77%
Kristofer Lundqvist
90,000SEK 463.5k0%no data
0.63%
Nadim Moued
73,931SEK 380.7k0%no data
0.51%
Niklas Gillback
60,129SEK 309.7k0%no data
0.47%
Ana Eggers
54,686SEK 281.6k0%no data
0.44%
Andre Nyvoll
51,864SEK 267.1k0%no data
0.23%
Christoph Nowak
27,000SEK 139.1k0%no data
0.085%
Michael Owens
10,000SEK 51.5k0%no data
0.0081%
FCG Fonder AB
948SEK 4.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 22:09
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OncoZenge AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin SuleRedeye